Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis

Toxicological Sciences

Volumn 47, Issue 1, 1999, Pages 1-8

  Vanden Heuvel, John P ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Hepatic mitogens; Peroxisome proliferator activated receptors (PPAR); Peroxisome proliferators (PP); Rats

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; FATTY ACID DERIVATIVE; FIBRIC ACID DERIVATIVE; HERBICIDE; INDUSTRIAL CHEMICAL; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PLASTICIZER; RECEPTOR SUBTYPE; TROGLITAZONE; TUMOR PROMOTER;

APOPTOSIS; CANCER RISK; CARCINOGENESIS; CELL DIFFERENTIATION; GENE EXPRESSION; HUMAN; NONHUMAN; POLLUTANT; REVIEW; RISK ASSESSMENT; TUMOR PROMOTION;

ANIMALS; CARCINOGENS; GENE EXPRESSION REGULATION; HUMANS; MITOGENS; NUCLEAR PROTEINS; PEROXISOME PROLIFERATORS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RISK ASSESSMENT; TRANSCRIPTION FACTORS;

EID: 0032962921     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/47.1.1     Document Type: Review

References (72)

1. Altiok, S., Xu, M., and Spiegelman, B. M. (1997). PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev. 11, 1987-1998.
2. Aoyama, T., Peters, J. M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T., and Gonzalez, F. J. (1998). Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J. Biol. Chem. 273, 5678-5684.
3. Ashby, J., Brady, A., Elcombe, C. R., Elliott, B. M., Ishmael, J., Odum, J., Tugwood, J. D., Kettle, S., and Purchase, I. F. (1994). Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol 13(Suppl. 2), S1-117.
4. Auboeuf, D., Rieusset, J., Fajas, L., Vallier, P., Frering, V., Riou, J. P., Staels, B., Auwerx, J., Laville, M., and Vidal, H. (1997). Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes 48, 1319-1327.
5. Bardot, O., Clemencet, M. C., Malki, M. C., and Latruffe, N. (1995). Delayed effects of ciprofibrate on rat liver peroxisomal properties and proto-oncogene expression. Biochem. Pharmacol. 50, 1001-1006.
6. Bayly, A. C., Roberts, R. A., and Dive, C. (1994). Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J. Cell. Biol. 125, 197-203.
7. Belury, M. A., Moya-Camarena, S. Y., Liu, L.-L., and Vanden Heuvel, J. P. (1997). Dietary conjugated linoleic acid induces peroxisome-specific enzyme accumulation and ornithine decarboxylase activity in mouse liver. J. Nutr. Biochem. 8, 579-584.
8. Belury, M. A., Moya-Camarena, S. Y., Sun, H., Snyder, E., Davis II, J. W., Cunningham, M. L., and Vanden Heuvel, J. P. (1998). Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver. Toxicol. Appl. Pharmacol. 151, 254-261.
9. Belury, M. A., and Vanden Heuvel, J. P. (1997). Protection against cancer and heart disease by the dietary fat, conjugated linoleic acid: Potential mechanisms of action. Nutr. Disease Update Journal, 1, 58-63.
10. Bentley, P., Calder, I., Elcombe, C., Grasso, P., Stringer, D., and Wiegand, H. J. (1993). Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem. Toxicol. 31, 857-907.
11. Berger, J., Bailey, P., Biswas, C., Cullinan, C. A., Doebber, T. W., Hayes, N. S., Saperstein, R., Smith, R. G., and Leibowitz, M. D. (1996). Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: Binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137, 4189-4195.
12. Biegel, L. B., Hurtt, M. E., Frame, S. R., Applegate, M., O'Conner, J. C., and Cook, J. C. (1992). Comparison of the effects of Wyeth-14,643 in Crl:CD BR and Fisher-344 rats. Fundam. Appl. Toxicol. 19, 590-597.
13. Bojes, H. K., Germolec, D. R., Simeonova, P., Bruccoleri, A., Schoonhoven, R., Luster, M. I., and Thurman, R. G. (1997). Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643. Carcinogenesis 18, 669-674.
14. Braissant, O., Foufelle, F., Scotto, C., Dauca, M., and Wahli, W. (1996). Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137, 354-366.
15. Brown, P. J., Smith-Oliver, T. A., Charifson, P. S., Tomkinson, N. C., Fivush, A. M., Sternbach, D. D., Wade, L. E., Orband-Miller, L., Parks, D. J., Blanchard, S. G., Kliewer, S. A., Lehmann, J. M., and Willson, T. M. (1997). Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library. Chem. Biol. 4, 909-918.
16. Cherkaoui-Malki, M., Lone, Y. C., Corral-Debrinski, M., and Latruffe, N. (1990). Differential proto-oncogene mRNA induction from rats treated with peroxisome proliferators. Biochem. Biophys. Res. Commun. 173, 855-861.
17. Dowell, P., Ishmael, J. E., Avram, D., Peterson, V. J., Nevrivy, D. J., and Leid, M. (1997). p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha. J. Biol Chem. 272, 33435-33443.
18. Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., and Wahli, W. (1992). Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68, 879-887.
19. Evans, R. M. (1988). The steroid and thyroid hormone receptor superfamily. Science 240, 889-895.
20. Fajas, L., Auboeuf, D., Raspe, E., Schoonjans, K., Lefebvre, A. M., Saladin, R., Najib, J., Laville, M., Fruchart, J. C., Deeb, S., Vidal-Puig, A., Flier, J., Briggs, M. R., Staels, B., Vidal, H., and Auwerx, J. (1997). The organization, promoter analysis, and expression of the human PPARgamma gene. J. Biol. Chem. 272, 18779-18789.
21. Gariot, P., Barrat, E., Mejean, L., Pointel, J. P., Drouin, P., and Debry, G. (1983). Fenofibrate and human liver. Lack of proliferation of peroxisomes. Arch. Toxicol. 53, 151-163.
22. Glauert, H. P., Reddy, J. K., Kennan, W. S., Sattler, G. L., Rao, V. S., and Pitot, H. C. (1984). Effect of hypolipidemic peroxisome proliferators on unscheduled DNA synthesis in cultured hepatocytes and on mutagenesis in Salmonella. Cancer Lett. 24, 147-156.
23. Gottlicher, M., Widmark, E., Li, Q., and Gustafsson, J. A. (1992). Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 89, 4654-4657.
24. Granneman, J., Skoff, R., and Yang, X. (1998). Member of the peroxisome proliferator-activated receptor family of transcription factors is differentially expressed in oligodendrocytes. Journal of Neuroscience Research 51, 563-573.
25. Green, S. (1992). Peroxisome proliferators: A model for receptor mediated carcinogenesis. Cancer Surv. 14, 221-232.
26. Grimaldi, P. A., Teboul, L., Inadera, H., Gaillard, D., and Amri, E. Z. (1997). Trans-differentiation of myoblasts to adipoblasts: Triggering effects of fatty acids and thiazolidinediones. Prostaglandins Leukot. Essent. Fatty Acids 57, 71-75.
27. Hanley, K., Yan, J., He, S. S., Friedman, M., Elias, P. M., Bikle, D. D., Williams, M. L., and Feingold, K. R. (1998). Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARα. J. Invest. Dermatol. 110, 368-375.
28. Huang, Q., Alvares, K., Chu, R., Bradfield, C. A., and Reddy, J. K. (1994). Association of peroxisome proliferator-activated receptor and Hsp72. J. Biol. Chem. 269, 8493-8497.
29. Issemann, I., and Green, S. (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators [see Comments]. Nature 347, 645-650.
30. Issemann, I., Prince, R., Tugwood, J., and Green, S. (1992). A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation? Biochem. Soc. Trans. 20, 824-827.
31. Karam, W. G., and Ghanayem, B. I. (1997). Induction of replicative DNA synthesis and PPAR alpha-dependent gene transcription by Wy-14 643 in primary rat hepatocyte and non-parenchymal cell co-cultures. Carcinogenesis 18, 2077-2083.
32. Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., and Evans, R. M. (1992). Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358, 771-774.
33. Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., and Lehmann, J. M. (1995). A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83, 813-819.
34. Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., and Lehmann, J. M. (1997). Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. USA 94, 4318-4323.
35. Krey, G., Braissant, O., L'Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., and Wahli, W. (1997). Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11, 779-791.
36. Ledwith, B. J., Manam, S., Troilo, P., Joslyn, D. J., Galloway, S. M., and Nichols, W. W. (1993). Activation of immediate-early gene expression by peroxisome proliferators in vitro. Mol. Carcinog. 8, 20-27.
37. Ledwith, B. J., Johnson, T. E., Wagner, L. K., Pauley, C. J., Manam, S., Galloway, S. M., and Nichols, W. W. (1996). Growth regulation by peroxisome proliferators: Opposing activities in early and late G1. Cancer Res. 56, 3257-3264.
38. Ledwith, B. J., Pauley, C. J., Wagner, L. K., Rokos, C. L., Alberts, D. W., and Manam, S. (1997). Induction of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol 12,13-myristate-type tumor promoters in immortalized mouse liver cells. J. Biol. Chem. 272, 3707-3714.
39. Lee, S. S., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., and Gonzalez, F. J. (1995). Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15, 3012-3022.
40. Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., and Kliewer, S. A. (1995). An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270, 12953-12956.
41. Lock, E. A., Mitchell, A. M., and Elcombe, C. R. (1989). Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu. Rev. Pharmacol. Toxicol. 29, 145-163.
42. Marsman, D. S., Cattley, R. C., Conway, J. G., and Popp, J. A. (1988). Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res. 48, 6739-6744.
43. Miyata, K. S., McCaw, S. E., Patel, H. V., Rachubinski, R. A., and Capone, J. P. (1996). The orphan nuclear hormone receptor LXR alpha interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling. J. Biol. Chem. 271, 9189-9192.
44. Mizukami, J., and Taniguchi, T. (1997). The antidiabetic agent thiazolidinedione stimulates the interaction between PPAR gamma and CBP. Biochem. Biophys. Res. Commun. 240, 61-64.
45. Moody, D. E., Reddy, J. K., Lake, B. G., Popp, J. A., and Reese, D. H. (1991). Peroxisome proliferation and nongenotoxic carcinogenesis: commentary on a symposium. Fundam. Appl. Toxicol. 16, 233-248.
46. Muerhoff, A. S., Griffin, K. J., and Johnson, E. F. (1992). The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid. J. Biol. Chem. 267, 19051-19053.
47. Peters, J. M., Cattley, R. C., and Gonzalez, F. J. (1997). Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 18, 2029-2033.
48. Peters, J. M., Hennuyer, N., Staels, B., Fruchart, J. C., Fievet, C., Gonzalez, F. J., and Auwerx, J. (1997). Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice. J. Biol. Chem. 272, 27307-27312.
49. Pineau, T., Hudgins, W. R., Liu, L., Chen, L. C., Sher, T., Gonzalez, F. J., and Samid, D. (1996). Activation of a human peroxisome proliferator-activated receptor by the antitumor agent phenylacetate and its analogs. Biochem. Pharmacol. 52, 659-667.
50. Reddy, J. K., and Krishnakantha, T. P. (1975). Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate. Science 190, 787-789.
51. Reddy, J. K., and Lalwani, N. D. (1983). Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol. 12, 1-58.
52. Reddy, J. K., and Rao, M. S. (1977). Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator. J. Natl. Cancer Inst. 59, 1645-1650.
53. Roberts, R. A. (1996). Non-genotoxic hepatocarcinogenesis: Suppression of apoptosis by peroxisome proliferators. Ann. N. Y. Acad. Sci. 804, 588-611.
54. Roberts, R. A., James, N. H., Woodyatt, N. J., Macdonald, N., and Tugwood, J. D. (1998). Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPARalpha). Carcinogenesis 19, 43-48.
55. Roberts, R. A., Nebert, D. W., Hickman, J. A., Richburg, J. H., and Goldsworthy, T. L. (1997). Perturbation of the mitosis/apoptosis balance: a fundamental mechanism in toxicology. Fundam. Appl. Toxicol. 38, 107-115.
56. Rokos, C. L., and Ledwith, B. J. (1997). Peroxisome proliferators activate extracellular signal-regulated kinases in immortalized mouse liver cells. J. Biol. Chem. 272, 13452-13457.
57. Rose, M. L., Germolec, D. R., Schoonhoven, R., and Thurman, R. G. (1997). Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators. Carcinogenesis 18, 1453-1456.
58. Sakai, M., Matsushima-Hibiya, Y., Nishizawa, M., and Nishi, S. (1995). Suppression of rat glutathione transferase P expression by peroxisome proliferators: interaction between Jun and peroxisome proliferator-activated receptor alpha. Cancer Res. 55, 5370-5376.
59. Schoonjans, K., Martin, G., Staels, B., and Auwerx, J. (1997). Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr. Opin. Lipidol. 8, 159-166.
60. Schoonjans, K., Staels, B., and Auwerx, J. (1996). The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta. 1302, 93-109.
61. Sher, T., Yi, H. F., McBride, O. W., and Gonzalez, F. J. (1993). cDna cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32, 5598-5604.
62. Spiegelman, B. M., Hu, E., Kim, J. B., and Brun, R. (1997). PPAR gamma and the control of adipogenesis. Biochimie 79, 111-112.
63. Sterchele, P. F., Sun, H., Peterson, R. E., and Vanden Heuvel, J. P. (1996). Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver. Arch. Biochem. Biophys. 326, 281-289.
64. Tontonoz, P., Hu, E., and Spiegelman, B. M. (1994). Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor [published erratum appears in Cell 1995 Mar 24;80(6): following 957]. Cell 79, 1147-1156.
65. Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., and Evans, R. M. (1998). PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241-252.
66. Tugwood, J. D., Aldridge, T. C., Lambe, K. G., Macdonald, N., and Woodyatt, N. J. (1996). Peroxisome proliferator-activated receptors: structures and function. Ann. N. Y. Acad. Sci. 804, 252-265.
67. Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., and Green, S. (1992). The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. Embo. J. 11, 433-439.
68. Vanden Heuvel, J. P. (1996). Perfluorodecanoic acid as a useful pharmacologic tool for the study of peroxisome proliferation. Gen. Pharmacol. 27, 1123-1129.
69. Vanden Heuvel, J. P., Holden, P., Tugwood, J., Ingle, C., Yen, W., Galjart, N., and Greenlee, W. F. (1998). Identification of a novel peroxisome proliferator responsive cDNA isolated from rat hepatocytes as the zinc-finger protein ZFP-37. Toxicol. Appl. Pharmacol 152, 107-118.
70. Zhang, B., Marcus, S. L., Miyata, K. S., Subramani, S., Capone, J. P., and Rachubinski, R. A. (1993). Characterization of protein-DNA interactions within the peroxisome proliferator-responsive element of the rat hydratase-dehydrogenase gene. J. Biol. Chem. 268, 12939-12945.
71. Zhu, Y., Qi, C., Calandra, C., Rao, M. S., and Reddy, J. K. (1996). Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor gamma. Gene Expr. 6, 185-195.
72. Zhu, Y., Qi, C., Jain, S., Rao, M. S., and Reddy, J. K. (1997). Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor. J. Biol. Chem. 272, 25500-25506.